GDP growth is projected to moderate from 2.8% in 2024 to 2.5% in 2025 and 1.7% in 2026. Output growth in the pharmaceutical sector will continue to sustain higher activity, albeit at a slower pace. Domestic demand will strengthen, supported by stronger household purchasing power, lower interest rates and a housing market recovery. Inflation will reach 2% in 2025 and 2026, as wage growth slows. Labour market tightness is projected to ease, but persistent skills shortages in key areas remain. Heightened geopolitical tensions and trade restrictions could curb activity in key sectors, including maritime transport and the pharmaceutical industry.
The central bank is expected to gradually reduce policy rates in line with the European Central Bank. The fiscal surplus will narrow in 2025 and 2026. While public debt is low, the government should follow its medium-term plans and avoid creating inflationary pressures in the economy. Any additional spending needs to be targeted at priority areas, including targeted cuts in effective labour income taxation and further education reform to address skills shortages.